Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

urinary incontinence/náusea

O link é salvo na área de transferência
Página 1 a partir de 77 resultados

[Long-term use of ovestin by postmenopausal women with urinary incontinence].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The aim of the study was to improve diagnosis and treatment of women suffering from clinical manifestations of urogenital atrophy in menopause: stress and urgent urine incontinence, disturbances of urination, recurrent infections of the lower urinary tracts. A total of 237 menopausal women were

Pharmacotherapy for stress urinary incontinence : present and future options.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Stress urinary incontinence (SUI) is the accidental leakage of urine associated with physical activities such as running, jumping or lifting, or with sneezing and coughing. Worldwide, SUI is a highly prevalent condition, both in young and elderly women, and is a condition fraught with social

A case of urinary incontinence by hydroxychloroquine in a geriatric patient.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE Rheumatoid arthritis is an autoimmune disorder characterized by persistent synovitis and systemic inflammation. Genetic factors account for approximately 50% of cases of rheumatoid arthritis and environmental factors include smoking. Urinary incontinence may occur as a medication adverse

Topiramate-associated urinary incontinence: a case verified by rechallenge.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Topiramate is an anticonvulsant that has been widely used in psychiatric conditions. The most common treatment-related adverse effects of topiramate were diarrhea, nausea, loss of appetite, fatigue, paresthesia, cognitive impairment, and metabolic acidosis. The following is a case report intended to

The efficacy of venlafaxine in the treatment of women with stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To examine the efficacy of venlafaxine, which is used as an antidepressant, in the treatment of stress urinary incontinence. METHODS The study was designed as a placebo-controlled, double-blind and randomized clinical study. Patients in Group 1 (n=20) were administered 75 mg venlafaxine,
BACKGROUND Antimuscarinic agents currently dominate medical treatment for urinary incontinence secondary to overactive bladder (OAB). Alternatives to improve their risk-benefit ratio are welcomed. OBJECTIVE To demonstrate the efficacy and safety of oral cizolirtine citrate in this

[Place of duloxetine in the treatment of stress urinary incontinence].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Urinary incontinence is a public health problem, as more than three million women in France are concerned by this problem. The prevalence of stress urinary incontinence is about 40% among these women. Duloxetine is a molecule developed for the oral treatment of stress urinary incontinence. It is a

Safety and tolerability of duloxetine in women with stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND The serotonin/noradrenaline uptake inhibitor duloxetine has been shown to be effective in the medical treatment of stress urinary incontinence (SUI) in women. OBJECTIVE To review the safety and tolerability of duloxetine with SUI. METHODS A systematic Medline search for the key word

Duloxetine for management of stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE The aim of this article was to review data regarding the efficacy and tolerability of duloxetine, a selective serotonin (5-HT)-norepinephrine (NE) reuptake inhibitor that has received US Food and Drug Administration marketing approval for the treatment of major depressive disorder and

Pharmacotherapy for stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE In the absence of an effective and well tolerated drug for stress urinary incontinence, pharmacological therapy for this condition has remained in the off-label prescription of some products particularly estrogens and alpha-adrenergic agonists. In this review we provide an update of the

Duloxetine: in stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Duloxetine is an orally administered, balanced, dual serotonin and norepinephrine (noradrenaline) reuptake inhibitor that increases neural input to the urethral sphincter, thereby relieving the symptoms of stress urinary incontinence (SUI). Duloxetine 40 mg twice daily for 12 weeks reduced the

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Stress urinary incontinence (SUI) is the accidental leakage of urine associated with physical activities such as running, jumping or lifting or with sneezing and coughing. For many patients it can be a very bothersome symptom, causing social isolation, loss of self-esteem and increased financial

Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of

Duloxetine in the treatment of stress urinary incontinence.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Stress urinary incontinence (SUI) is the most common form of urinary incontinence and occurs more frequently in women than in men. Duloxetine is a balanced dual serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor and shows no relevant binding affinity for histaminergic, dopaminergic,
To assess the impact of duloxetine dose escalation on tolerability and efficacy, 516 women with stress urinary incontinence were randomized to receive placebo or duloxetine in one of three regimens: 40 mg BID for 8 weeks, 40 mg QD for 2 weeks escalating to 40 mg BID for 6 weeks or 20 mg BID for 2
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge